Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: A case report

Emanuele Romeo, Michele D'Alto, Maria Giovanna Russo, Berardo Sarubbi, Dominga Cardaropoli, Dario Paladini, Giuseppe Pacileo, Annalisa Annunziata, Raffaele Calabrò

Research output: Contribution to journalArticle

Abstract

Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal supraventricular tachycardia diagnosed at 24 weeks of gestation. The first-line treatment was oral maternal digoxin and sotalol. This therapy was not sufficient for complete control of the tachycardia. Hence, second-line treatment with digoxin and flecainide was started and successfully achieved conversion to sinus rhythm. No adverse maternal side effects were noted during the 14 weeks of therapy. A normal male infant was delivered at elective cesarean section performed for obstetric indications at 38 weeks of gestation. A persistent junctional reciprocating tachycardia with a ventriculo-atrial/ atrioventricular ratio > 1 was diagnosed following delivery at transesophageal electrophysiological study. At the age of 8 months the child is on therapy with sotalol (4 mg/kg/day) and flecainide (3 mg/kg/ day) and is in good clinical conditions.

Original languageEnglish
Pages (from-to)777-780
Number of pages4
JournalItalian Heart Journal
Volume5
Issue number10
Publication statusPublished - Oct 2004

Fingerprint

Supraventricular Tachycardia
Parturition
Pregnancy
Flecainide
Sotalol
Digoxin
Tachycardia
Therapeutics
Reciprocating Tachycardia
Cardiac Electrophysiologic Techniques
Electric Countershock
Third Pregnancy Trimester
Second Pregnancy Trimester
Cesarean Section
Obstetrics
Mothers

Keywords

  • Arrhythmias
  • Digoxin
  • Fetal echocardiography
  • Flecainide
  • Sotalol
  • Supraventricular

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Romeo, E., D'Alto, M., Russo, M. G., Sarubbi, B., Cardaropoli, D., Paladini, D., ... Calabrò, R. (2004). Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: A case report. Italian Heart Journal, 5(10), 777-780.

Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth : A case report. / Romeo, Emanuele; D'Alto, Michele; Russo, Maria Giovanna; Sarubbi, Berardo; Cardaropoli, Dominga; Paladini, Dario; Pacileo, Giuseppe; Annunziata, Annalisa; Calabrò, Raffaele.

In: Italian Heart Journal, Vol. 5, No. 10, 10.2004, p. 777-780.

Research output: Contribution to journalArticle

Romeo, E, D'Alto, M, Russo, MG, Sarubbi, B, Cardaropoli, D, Paladini, D, Pacileo, G, Annunziata, A & Calabrò, R 2004, 'Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: A case report', Italian Heart Journal, vol. 5, no. 10, pp. 777-780.
Romeo, Emanuele ; D'Alto, Michele ; Russo, Maria Giovanna ; Sarubbi, Berardo ; Cardaropoli, Dominga ; Paladini, Dario ; Pacileo, Giuseppe ; Annunziata, Annalisa ; Calabrò, Raffaele. / Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth : A case report. In: Italian Heart Journal. 2004 ; Vol. 5, No. 10. pp. 777-780.
@article{caf94787ac9d4b359cfbe6362755b566,
title = "Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: A case report",
abstract = "Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal supraventricular tachycardia diagnosed at 24 weeks of gestation. The first-line treatment was oral maternal digoxin and sotalol. This therapy was not sufficient for complete control of the tachycardia. Hence, second-line treatment with digoxin and flecainide was started and successfully achieved conversion to sinus rhythm. No adverse maternal side effects were noted during the 14 weeks of therapy. A normal male infant was delivered at elective cesarean section performed for obstetric indications at 38 weeks of gestation. A persistent junctional reciprocating tachycardia with a ventriculo-atrial/ atrioventricular ratio > 1 was diagnosed following delivery at transesophageal electrophysiological study. At the age of 8 months the child is on therapy with sotalol (4 mg/kg/day) and flecainide (3 mg/kg/ day) and is in good clinical conditions.",
keywords = "Arrhythmias, Digoxin, Fetal echocardiography, Flecainide, Sotalol, Supraventricular",
author = "Emanuele Romeo and Michele D'Alto and Russo, {Maria Giovanna} and Berardo Sarubbi and Dominga Cardaropoli and Dario Paladini and Giuseppe Pacileo and Annalisa Annunziata and Raffaele Calabr{\`o}",
year = "2004",
month = "10",
language = "English",
volume = "5",
pages = "777--780",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "10",

}

TY - JOUR

T1 - Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth

T2 - A case report

AU - Romeo, Emanuele

AU - D'Alto, Michele

AU - Russo, Maria Giovanna

AU - Sarubbi, Berardo

AU - Cardaropoli, Dominga

AU - Paladini, Dario

AU - Pacileo, Giuseppe

AU - Annunziata, Annalisa

AU - Calabrò, Raffaele

PY - 2004/10

Y1 - 2004/10

N2 - Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal supraventricular tachycardia diagnosed at 24 weeks of gestation. The first-line treatment was oral maternal digoxin and sotalol. This therapy was not sufficient for complete control of the tachycardia. Hence, second-line treatment with digoxin and flecainide was started and successfully achieved conversion to sinus rhythm. No adverse maternal side effects were noted during the 14 weeks of therapy. A normal male infant was delivered at elective cesarean section performed for obstetric indications at 38 weeks of gestation. A persistent junctional reciprocating tachycardia with a ventriculo-atrial/ atrioventricular ratio > 1 was diagnosed following delivery at transesophageal electrophysiological study. At the age of 8 months the child is on therapy with sotalol (4 mg/kg/day) and flecainide (3 mg/kg/ day) and is in good clinical conditions.

AB - Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal supraventricular tachycardia diagnosed at 24 weeks of gestation. The first-line treatment was oral maternal digoxin and sotalol. This therapy was not sufficient for complete control of the tachycardia. Hence, second-line treatment with digoxin and flecainide was started and successfully achieved conversion to sinus rhythm. No adverse maternal side effects were noted during the 14 weeks of therapy. A normal male infant was delivered at elective cesarean section performed for obstetric indications at 38 weeks of gestation. A persistent junctional reciprocating tachycardia with a ventriculo-atrial/ atrioventricular ratio > 1 was diagnosed following delivery at transesophageal electrophysiological study. At the age of 8 months the child is on therapy with sotalol (4 mg/kg/day) and flecainide (3 mg/kg/ day) and is in good clinical conditions.

KW - Arrhythmias

KW - Digoxin

KW - Fetal echocardiography

KW - Flecainide

KW - Sotalol

KW - Supraventricular

UR - http://www.scopus.com/inward/record.url?scp=16644369065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644369065&partnerID=8YFLogxK

M3 - Article

C2 - 15626276

AN - SCOPUS:16644369065

VL - 5

SP - 777

EP - 780

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 10

ER -